Health Care/Hospital News & Press Release Distribution

Shenzhen to Foster Quantitative Biology Stronghold

SHENZHEN, China, Aug. 3, 2023 /PRNewswire/ -- An international conference on quantitative biology was held recently inSouthern China's Shenzhen, drawing over 300 participants from more than 20 universities worldwide to discuss illuminating opportunities and shaping the future of quantitative and ...

2023-08-03 21:34 2059

Shenzhen to Foster Quantitative Biology Stronghold

SHENZHEN, China, Aug. 3, 2023 /PRNewswire/ -- An international conference on quantitative biology was held recently inSouthern China's Shenzhen, drawing over 300 participants from more than 20 universities worldwide to discuss illuminating opportunities and shaping the future of quantitative and ...

2023-08-03 19:00 1404

JinMed's Nanobathing Products Receive Multiple Patent Certifications and Sign Directed Procurement Agreement with Shanghai Zhongjin HongKang Medical Technology

CHANGZHOU, China, Aug. 3, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("the Company" or "JinMed") (NASDAQ: ZJYL) which is the world's leading provider of rehabilitation equipment. Currently, the Company's nanobathing products have been granted an invention patent and four utility model pa...

2023-08-03 17:13 955

MANA Develops Novel "Drycell" Microdroplets to Make Handling Single Cell Easier

TSUKUBA, Japan, Aug. 3, 2023 /PRNewswire/ -- Scientists at the Research Center for Materials Nanoarchitectonics (MANA) have developed micrometer-sized "liquid marbles" that can encapsulate single to several living cells, thereby aiding single-cell studies. To analyze individual cells, the desire...

2023-08-03 16:00 919

The Adecco Group: HALF YEAR Report 2023

AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange ZURICH, Aug. 3, 2023 /PRNewswire/ -- The Adecco Group Half Year Report 2023 is now available in the Ad Hoc section of the Group's website, which is directly accessible by clickinghere

2023-08-03 12:45 1234

SayHeart Announces AI-Powered Visual-to-Text Transformation Pilot Testing for Dental X-Rays, with Kindlehouse Dentistry Partnership

KUALA LUMPUR, Malaysia, Aug. 3, 2023 /PRNewswire/ -- SayHeart, the groundbreaking health tech firm, is excited to announce the beginning of its pilot testing phase for a revolutionary visual-to-text transformation feature, focusing on dental X-ray images. This advanced AI-driven solution is aimed...

2023-08-03 12:40 2235

SayHeart Announces AI-Powered Visual-to-Text Transformation Pilot Testing for Dental X-Rays, with Kindlehouse Dentistry Partnership

Cicada Innovations to launch new incubator at Westmead Health & Innovation District, backed by Investment NSW

SYDNEY, Aug. 3, 2023 /PRNewswire/ -- Australia's flagship deep tech incubator Cicada Innovations is expanding with the opening of a health-focused incubator at one ofAustralia's largest health and biomedical research precincts, the Westmead Health and Innovati...

2023-08-03 12:15 1955

Cicada Innovations to launch new incubator at Westmead Health & Innovation District, backed by Investment NSW

Public Medicare Group Sdn Bhd and Dr. Chieng King Chong Win Fast Enterprise and Master Entrepreneur Accolades at the Asia Pacific Enterprise Awards 2023 Malaysia

SINGAPORE, Aug. 3, 2023 /PRNewswire/ -- Renowned Malaysian healthcare provider Public Medicare Group Sdn Bhd (PMG) celebrates a remarkable double triumph at the prestigious Asia Pacific Enterprise Awards (APEA) 2023 Malaysia. The company has been honored with the distinguished Fast Enterprise Awa...

2023-08-03 11:55 1426

ESMO 2023 | Ascentage Pharma to Present Results from Two Clinical Studies, including One Oral Presentation, at 2023 ESMO Congress

SUZHOU, China, and ROCKVILLE, Md., Aug. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it is going to release results from two clinic...

2023-08-03 11:43 1132

SK Biopharmaceuticals Assembles 'Board of Prominent Experts' to Boost Growth, Innovation

Renowned oncologist Yung-Jue Bang, M.D., Ph.D., chairs the distinguished 5-member Scientific Advisory Board to further advance SK Biopharmaceuticals as a global big biotech SEOUL, South Korea, Aug. 2, 2023 /PRNewswire/ -- SK Biopharmaceuticals, a global biotech company, announced the formation o...

2023-08-03 07:30 1151

Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting

SYDNEY, Aug. 2, 2023 /PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO Breakthrough c...

2023-08-03 07:00 1029

U.S. FDA Grants Orphan Drug Designation to ABM-1310 for the Treatment of Patients with Glioblastoma Harboring BRAF V600 Mutation

SAN DIEGO and SHANGHAI, Aug. 2, 2023 /PRNewswire/ -- ABM Therapeutics (ABM) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ABM-1310, a novel small molecule BRAF inhibitor developed by the company, for the treatment of patients with g...

2023-08-03 00:00 1045

3B Scientific acquires Lifecast Body Simulation

HAMBURG, Germany, Aug. 2, 2023 /PRNewswire/ -- 3B Scientific, a leading manufacturer and marketer of medical simulation products and anatomical models for healthcare education, announces today that it has reached an agreement to acquire Lifecast Body Simulation. Launched in 2017, Lifecast ...

2023-08-02 15:00 1568

Atantares has Completed Two Rounds of RMB100 Million Financing, and the Pre-A Round is led by Asia Green Fund

BEIJING, Aug. 2, 2023 /PRNewswire/ -- Recently, Atantares announced the completion of Pre-A and Pre-A+ financing all aroundRMB100 million. The Pre-A round is led by Asia Green Fund, followed by Fosun Health Capital and existing investors Frees Fund, Qiming Venture Partners, Next Capital, and NeuX...

2023-08-02 14:56 1397

Unlocking the Power of Genetics: Camtech Unveils DNA Self-Test Kits for Holistic Wellness

SINGAPORE, Aug. 2, 2023 /PRNewswire/ -- Camtech Diagnostics, a provider of innovative healthcare testing solutions, is excited to announce the launch of its Ideal Health DNA Test this September. This powerful genetic testing kit...

2023-08-02 14:42 1604

Peter Mac launches BindiMaps to help patients and visitors with vision impairments

SYDNEY, Aug. 2, 2023 /PRNewswire/ -- The world-leading Peter MacCallum Cancer Centre has become the first hospital inVictoria to offer accessibl...

2023-08-02 14:00 1504

Peter Mac launches BindiMaps to help patients and visitors with vision impairments

Six Laureates in Taiwan for the 5th Tang Prize Award Ceremony

TAIPEI, Aug. 2, 2023 /PRNewswire/ -- The 5th Tang Prize Award Ceremony was held at 14:30 (GMT+8) onAugust 1 in the Howard Civil Service International House in Taipei. Prominent attendees included six 2022 Tang Prize laureates, who flew to Taiwan from different parts of the world for this memorabl...

2023-08-02 12:24 1476

Six Laureates in Taiwan for the 5th Tang Prize Award Ceremony

NAVI CLOSES $2.4 MILLION FOR ITS BREAKTHROUGH MEDICAL DEVICE TO HELP CRITICALLY ILL NEWBORN BABIES

Key points: * After a successful raise Navi Medical Technologies has closed a $2.4 million round of funding, which included a$700,000 lead investment from Breakthrough Victoria. * The company's innovative Neonav® ECG Tip Location System is designated as a Breakthrough medical device by the U...

2023-08-02 08:00 1619

Selected for oral presentation! Kelun-Biotech to announce latest clinical study results of SKB264 (MK-2870, TROP2-ADC) for treatment of HR+/HER2- breast cancer at ESMO Congress 2023

CHENGDU, China, Aug. 1, 2023 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990.HK) announced that it will present the data from a Phase I/II clinical trial of the innovative TROP2-ADC (SKB264, MK-2870) jointly developed by Kelun-Biotech and MSD (the t...

2023-08-01 21:07 2008

Lunit Presents Groundbreaking Study on Predicting Treatment Response by HER2 Analysis in Colorectal Cancer

- Collaborative study with NCCHE shows that AI analysis of HER2 expression and the tumor microenvironment is linked to treatment response of Pertuzumab+Trastuzumab in colorectal cancer SEOUL, South Korea, Aug. 1, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered soluti...

2023-08-01 21:00 1410